BlackRock Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$61K	Hold	26,095	–	–	﹤0.01%	3208
2016 Q3	$44K	Hold	26,095	–	–	﹤0.01%	3290
2016 Q2	$27K	Sell	26,095 -50,865	-66%	-$49.1K	﹤0.01%	3377
2016 Q1	$67K	Buy	76,960 +10,102	+15%	+$9.78K	﹤0.01%	3086
2015 Q4	$81K	Sell	66,858 -35,548	-35%	-$49.5K	﹤0.01%	3017
2015 Q3	$174K	Buy	102,406 +1,024	+1%	+$2.01K	﹤0.01%	2806
2015 Q2	$211K	Buy	101,382 +22,927	+29%	+$55.6K	﹤0.01%	2767
2015 Q1	$213K	Buy	78,455 +11,287	+17%	+$28.6K	﹤0.01%	2637
2014 Q4	$173K	Sell	67,168 -4,120	-6%	-$9.26K	﹤0.01%	2724
2014 Q3	$130K	Sell	71,288 -1,330	-2%	-$2.9K	﹤0.01%	2861
2014 Q2	$194K	Sell	72,618 -8,638	-11%	-$26K	﹤0.01%	2655
2014 Q1	$284K	Buy	81,256 +4,397	+6%	+$19.5K	﹤0.01%	2444
2013 Q4	$344K	Buy	76,859 +5,298	+7%	+$21.6K	﹤0.01%	2315
2013 Q3	$291K	Buy	71,561 +2,272	+3%	+$9.92K	﹤0.01%	2303
2013 Q2	$288K	Buy	+69,289	New	+$268K	﹤0.01%	2236

Other funds holding ATRS

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock Advisors's ATRS Position: Q4 2016 in Review

BlackRock Advisors held its Antares Pharma, Inc. (ATRS) position steady in Q4 2016 at 26,095 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

BlackRock Advisors first reported a position in ATRS in Q2 2013 and has held it in 15 quarters since. The position peaked at $344K in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q4 2016.

BlackRock Advisors held 26,095 shares of Antares Pharma, Inc. worth $61K as of Q4 2016.
BlackRock Advisors left its Antares Pharma, Inc. share count unchanged in Q4 2016.
Antares Pharma, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3208 holding.
BlackRock Advisors first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Antares Pharma, Inc. position peaked at $344K in Q4 2013.
71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.